Genotypic analysis of meningococcal factor H-binding protein from non-culture clinical specimens

PLoS ONE

Volumn 9, Issue 2, 2014, Pages

  Clark, Stephen A ^a   Lucidarme, Jay ^a   Newbold, Lynne S ^a   Borrow, Ray ^a  

^a MANCHESTER ROYAL INFIRMARY   (United Kingdom)

Author keywords

[No Author keywords available]

Indexed keywords

BACTERIAL DNA; FACTOR H BINDING PROTEIN; OUTER MEMBRANE PROTEIN; UNCLASSIFIED DRUG; BACTERIAL ANTIGEN; BACTERIAL PROTEIN; COMPLEMENT FACTOR H; FACTOR H-BINDING PROTEIN, NEISSERIA MENINGITIDIS; MENINGOCOCCUS VACCINE;

ALLELE; ARTICLE; BACTERIUM ISOLATE; BINDING SITE; CONTROLLED STUDY; DNA EXTRACTION; FHBP GENE; GENE AMPLIFICATION; GENE SEQUENCE; GENOTYPING TECHNIQUE; HUMAN; INTERMETHOD COMPARISON; NEISSERIA LACTAMICA; NEISSERIA MENINGITIDIS; NON CULTURE CLINICAL SPECIMEN; NONHUMAN; POLYMERASE CHAIN REACTION; REAL TIME POLYMERASE CHAIN REACTION; SENSITIVITY ANALYSIS; TISSUE SECTION; CHEMISTRY; DNA SEQUENCE; GENETICS; MENINGOCOCCAL INFECTIONS; METABOLISM; MOLECULAR GENETICS; NUCLEOTIDE SEQUENCE; SENSITIVITY AND SPECIFICITY; UNITED KINGDOM; VALIDATION STUDY;

ANTIGENS, BACTERIAL; BACTERIAL PROTEINS; BASE SEQUENCE; BINDING SITES; COMPLEMENT FACTOR H; ENGLAND; HUMANS; MENINGOCOCCAL INFECTIONS; MENINGOCOCCAL VACCINES; MOLECULAR SEQUENCE DATA; NEISSERIA MENINGITIDIS; POLYMERASE CHAIN REACTION; REAL-TIME POLYMERASE CHAIN REACTION; SENSITIVITY AND SPECIFICITY; SEQUENCE ANALYSIS, DNA; WALES;

EID: 84896078307     PISSN: None     EISSN: 19326203     Source Type: Journal    
DOI: 10.1371/journal.pone.0089921     Document Type: Article

References (30)

1. Borrow R, Abad R, Trotter C, van der Klis FRM, Vazquez JA (2013) Effectiveness of meningococcal serogroup C vaccine programmes. Vaccine 31: 4477-4486.
2. Halperin SA, Bettinger JA, Greenwood B, Harrison LH, Jelfs J, et al. (2012) The changing and dynamic epidemiology of meningococcal disease. Vaccine 30 Suppl 2: B26-36.
3. McIntyre PB, O'Brien KL, Greenwood B, van de Beek D (2012) Effect of vaccines on bacterial meningitis worldwide. Lancet 380: 1703-1711.
4. Daugla D, Gami J, Gamougam K, Naibei N, Mbainadji L, et al. (2013) Effect of a serogroup A meningococcal conjugate vaccine (PsA-TT) on serogroup A meningococcal meningitis and carriage in Chad: a community trial. Lancet in press.
5. Finne J, Leinonen M, Mäkelä PH (1983) Antigenic Similarities Between Brain Components And Bacteria Causing Meningitis: Implications for Vaccine Development and Pathogenesis. Lancet 322: 355-357. (Pubitemid 13028927)
6. Holst J, Oster P, Arnold R, Tatley M V, Næss LM, et al. (2013) Lessons from past programs and implications for the future vaccines against meningococcal serogroup B disease containing outer membrane vesicles (OMV). Hum Vaccin Immunother 9: 1241-1253.
7. Panatto D, Amicizia D, Lai PL, Gasparini R (2011) Neisseria meningitidis B vaccines. Expert Rev Vaccines 10: 1337-1351.
8. Mascioni A, Bentley BE, Camarda R, Dilts DA, Fink P, et al. (2009) Structural Basis for the Immunogenic Properties of the Meningococcal Vaccine Candidate LP2086. J Biol Chem 284: 8738-8746.
9. Cantini F, Veggi D, Dragonetti S, Savino S, Scarselli M, et al. (2009) Solution structure of the factor H-binding protein, a survival factor and protective antigen of Neisseria meningitidis. J Biol Chem 284: 9022-9026.
10. Fletcher LD, Bernfield L, Barniak V, John E, Howell A, et al. (2004) Vaccine Potential of the Neisseria meningitidis 2086 Lipoprotein. Infect Immun 72: 2088-2100. (Pubitemid 38419922)
11. Masignani V, Comanducci M, Giuliani MM, Bambini S, Adu-Bobie J, et al. (2003) Vaccination against Neisseria meningitidis using three variants of the lipoprotein GNA1870. J Exp Med 197: 789-799. (Pubitemid 36350873)
12. Madico G, Welsch JA, Lewis LA, McNaughton A, Perlman DH, et al. (2006) The meningococcal vaccine candidate GNA1870 binds the complement regulatory protein factor H and enhances serum resistance. J Immunol 177: 501-510. (Pubitemid 43939163)
13. Jolley KA, Maiden MCJ (2010) BIGSdb: Scalable analysis of bacterial genome variation at the population level. BMC Bioinformatics 11: 595.
14. Brehony C, Wilson DJ, Maiden MCJ (2009) Variation of the factor H-binding protein of Neisseria meningitidis. Microbiology 155: 4155-4169.
15. Jiang H-Q, Hoiseth SK, Harris SL, McNeil LK, Zhu D, et al. (2010) Broad vaccine coverage predicted for a bivalent recombinant factor H binding protein based vaccine to prevent serogroup B meningococcal disease. Vaccine 28: 6086-6093.
16. Richmond PC, Nissen MD, Marshall HS, Lambert SB, Roberton D, et al. (2012) A bivalent Neisseria meningitidis recombinant lipidated factor H binding protein vaccine in young adults: results of a randomised, controlled, dose-escalation phase 1 trial. Vaccine 30: 6163-6174.
17. Marshall HS, Richmond PC, Nissen MD, Wouters A, Baber J, et al. (2013) A phase 2 open-label safety and immunogenicity study of a meningococcal B bivalent rLP2086 vaccine in healthy adults. Vaccine 31: 1569-1575.
18. European Medicines Agency (2012) Bexsero Assessment report.
19. Novartis (2013) Novartis Bexsero Australia Approval Press Release.
20. Bai X, Findlow J, Borrow R (2011) Recombinant protein meningococcal serogroup B vaccine combined with outer membrane vesicles. Expert Opin Biol Ther 11: 969-985.
21. Heinsbroek E, Ladhani S, Gray S, Guiver M, Kaczmarski E, et al. (2013) Added value of PCR-testing for confirmation of invasive meningococcal disease in England. J Infect 67: 385-390.
22. Birtles A, Hardy K, Gray SJ, Handford S, Kaczmarski EB, et al. (2005) Multilocus Sequence Typing of Neisseria meningitidis Directly from Clinical Samples and Application of the Method to the Investigation of Meningococcal Disease Case Clusters. J Clin Microbiol 43: 6007-6014. (Pubitemid 43100652)
23. Diggle MA, Clarke SC (2003) Detection and genotyping of meningococci using a nested PCR approach. J Med Microbiol 52: 51-57. (Pubitemid 36106369)
24. Feil EJ, Li BC, Aanensen DM, Hanage WP, Spratt BG (2004) eBURST: Inferring Patterns of Evolutionary Descent among Clusters of Related Bacterial Genotypes from Multilocus Sequence Typing Data. J Bacteriol 186: 1518-1530. (Pubitemid 38248742)
25. Jolley KA, Bliss CM, Bennett JS, Bratcher HB, Brehony C, et al. (2012) Ribosomal Multi-Locus Sequence Typing: universal characterisation of bacteria from domain to strain. Microbiology 158: 1005-1015.
26. Lucidarme J, Gilchrist S, Newbold LS, Gray SJ, Kaczmarski EB, et al. (2013) Genetic Distribution of Noncapsular Meningococcal Group B Vaccine Antigens in Neisseria lactamica. Clin Vaccine Immunol 20: 1360-1369.
27. Corless CE, Guiver M, Borrow R, Edwards-Jones V, Fox AJ, et al. (2001) Simultaneous detection of Neisseria meningitidis, Haemophilus influenzae, and Streptococcus pneumoniae in suspected cases of meningitis and septicemia using real-time PCR. J Clin Microbiol 39: 1553-1558. (Pubitemid 32275465)
28. Bennett JS, Bentley SD, Vernikos GS, Quail MA, Cherevach I, et al. (2010) Independent evolution of the core and accessory gene sets in the genus Neisseria: insights gained from the genome of Neisseria lactamica isolate 020-06. BMC Genomics 11: 652.
29. Lucidarme J, Tan L, Exley RM, Findlow J, Borrow R, et al. (2011) Characterization of Neisseria meningitidis isolates that do not express the virulence factor and vaccine antigen factor H binding protein. Clin Vaccine Immunol 18: 1002-1014.
30. Jacobsson S, Thulin S, Mölling P, Unemo M, Comanducci M, et al. (2006) Sequence constancies and variations in genes encoding three new meningococcal vaccine candidate antigens. Vaccine 24: 2161-2168. (Pubitemid 43255159)